{
    "label": "Age of Patient?",
    "node_type": "fieldset",
    "children": [
        {
            "label": "For adults (age 18 years and older)",
            "outcome": "Authorization for Wegovy™ (semaglutide), may be approved when all of the criteria are met",
            "node_type": "radio",
            "node_value": false,
            "children": [
                {
                    "label": "Is this request for initiation or continuation of therapy with Wegovy™ (semaglutide)?",
                    "node_type": "fieldset",
                    "children": [
                        {
                            "label": "Start of therapy",
                            "outcome": "Initial Authorization for Wegovy™ (semaglutide) may be granted for 4 months when the criteria are met",
                            "node_type": "radio",
                            "node_value": false,
                            "children": [
                                {
                                    "label": "Which Weight-Related Risk Factors Does the Patient Have? (Must Have at Least One, Select All That Apply)",
                                    "all_required": true,
                                    "node_type": "checkbox",
                                    "node_value": false,
                                    "children": [
                                        {
                                            "label": "Established cardiovascular disease or stroke",
                                            "node_type": "checkbox",
                                            "node_value": false,
                                            "comorbidity": true
                                        },
                                        {
                                            "label": "Hypertension",
                                            "node_type": "checkbox",
                                            "node_value": false,
                                            "comorbidity": true
                                        },
                                        {
                                            "label": "Type 2 diabetes (DM)",
                                            "node_type": "checkbox",
                                            "node_value": false,
                                            "comorbidity": true
                                        },
                                        {
                                            "label": "Chronic kidney disease (CKD)",
                                            "node_type": "checkbox",
                                            "node_value": false,
                                            "comorbidity": true
                                        },
                                        {
                                            "label": "Congenital heart disease (CHD)",
                                            "node_type": "checkbox",
                                            "node_value": false,
                                            "comorbidity": true
                                        },
                                        {
                                            "label": "Obstructive sleep apnea",
                                            "node_type": "checkbox",
                                            "node_value": false,
                                            "comorbidity": true
                                        },
                                        {
                                            "label": "Polycystic ovarian syndrome",
                                            "node_type": "checkbox",
                                            "node_value": false,
                                            "comorbidity": true
                                        },
                                        {
                                            "label": "Dyslipidemia",
                                            "node_type": "checkbox",
                                            "node_value": false,
                                            "comorbidity": true
                                        },
                                        {
                                            "label": "Non-alcoholic fatty liver disease",
                                            "node_type": "checkbox",
                                            "node_value": false,
                                            "comorbidity": true
                                        },
                                        {
                                            "label": "Idiopathic intracranial hypertension",
                                            "node_type": "checkbox",
                                            "node_value": false,
                                            "comorbidity": true
                                        },
                                        {
                                            "label": "Osteoarthritis in weight-bearing joints",
                                            "node_type": "checkbox",
                                            "node_value": false,
                                            "comorbidity": true
                                        }
                                    ]
                                },
                                {
                                    "label": "Does the patient have access to a covered BCBSM/BCN program?",
                                    "node_type": "radio",
                                    "node_value": false,
                                    "children": [
                                        {
                                            "label": "Yes",
                                            "node_type": "checkbox",
                                            "node_value": false,
                                            "smart_engine": "over_18_initiation_with_BCBSM/BCN_program"
                                        },
                                        {
                                            "label": "No",
                                            "node_type": "checkbox",
                                            "node_value": false,
                                            "smart_engine": "over_18_initiation_without_BCBSM/BCN_program"
                                        }
                                    ]
                                },
                            ]
                        },
                        {
                            "label": "Continuation of therapy",
                            "outcome": "Reauthorization for Wegovy™ (semaglutide) may be granted when the criteria are met",
                            "node_type": "radio",
                            "node_value": false,
                            "smart_engine": "over_18_continuation":
                        }
                    ]
                }
            ]
        },
        {
            "label": "For adolescents (12 to 17 years of age)",
            "outcome": "Authorization for Wegovy™ (semaglutide), may be approved when all of the criteria are met",
            "node_type": "radio",
            "node_value": false,
            "children": [
                {
                    "label": "Is this request for initiation or continuation of therapy with Wegovy™ (semaglutide)?",
                    "node_type": "fieldset",
                    "children": [
                        {
                            "label": "Start of therapy",
                            "outcome": "Initial Authorization for Wegovy™ (semaglutide) may be granted for 4 months when the criteria are met",
                            "node_type": "radio",
                            "node_value": false,
                            "children": [
                                {
                                    "label": "Does the patient have access to a covered BCBSM/BCN program?",
                                    "node_type": "radio",
                                    "node_value": false,
                                    "children": [
                                        {
                                            "label": "Yes",
                                            "node_type": "checkbox",
                                            "node_value": false,
                                            "smart_engine": "below_18_initiation_with_BCBSM/BCN_program"
                                        },
                                        {
                                            "label": "No",
                                            "node_type": "checkbox",
                                            "node_value": false,
                                            "smart_engine": "18_plus_initiation_without_BCBSM/BCN_program"
                                        }
                                    ]    
                                },
                            ]
                        },
                        {
                            "label": "Continuation of therapy",
                            "outcome": "Reauthorization for Wegovy™ (semaglutide) may be granted when the criteria are met",
                            "node_type": "radio",
                            "node_value": false,
                            "smart_engine": "18_plus_continuation"
                        }
                    ]
                }
            ]
        }
    ]
}
